Ahead of its annual R&D Day event, Moderna Inc. says it now doesn't expect its revenue to equal its expenses until 2028, two years longer than it had previously predicted.
Moderna also announced new “portfolio prioritization and cost efficiencies,” which include discontinuing five early-stage programs and cutting its annual research and development expenses by $1.1 billion starting in 2027.
WATCH ANYTIME FOR FREE
 |
>Stream NBC10 Boston news for free, 24/7, wherever you are. |
More on this story from Boston Business Journal
Get updates on what's happening in Boston to your inbox. Sign up for our >News Headlines newsletter.
Copyright Boston Business Journal
